Research Infrastructure Programs

Active

Assistance listing
93.351
Agency
Grant awards
2,768 $5,728,088,538 in federal obligations

Program facts

Also known as
Comparative Medicine, Instrumentation, Research Infrastructure
Assistance types
  • Project Grant
  • Cooperative Agreement
Treasury account
  • 75-0846-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Institutes of Health Office of Research Infrastructure Programs funds construction and modernization of research facilities, cutting-edge scientific instrumentation, research models for human diseases, and research training opportunities for veterinary scientists under the Research Infrastructure Programs Assistance Listing (CFDA 93.351), with the most recent grant award dated September 15, 2026.

The program distributes grants at a steady cadence: 150 to 210 awards annually over the past five years, with combined federal obligations of $5.73 billion across 2,768 total awards since 1977. Funding is heavily concentrated in the NIH Office of the Director, which accounts for 1,791 awards ($4.38 billion federal dollars obligated), followed by NIH general funding (781 awards, $470.9 million) and the broader Department of Health and Human Services (180 awards, $135.1 million). Awards are predominantly Project Grants (99%), with Cooperative Agreements making up the remainder. Recent award magnitudes range from $30,000 conference grants to $3.68 billion for specialized instrumentation; typical facility equipment purchases cluster between $150 thousand and $2 million.

Awarded activities span construction and renovation of vivaria, acquisition of high-field imaging systems (MRI, PET/CT, electron microscopy), advanced analytical instruments (mass spectrometers, NMR spectrometers, cryo-EM), high-throughput screening platforms, and development of specialized research models including transgenic rodents, zebrafish xenograft systems, and porcine stem cell platforms. Recent awards also fund infrastructure modernization (cage washers, sterilization systems), computational resources, and development of new approach methodologies as complements to traditional animal models.

Multiple opportunities remain open or recently posted. PAR-28-060 invites applications for small instruments and equipment for shared-use biomedical research facilities (due August 24, 2026). PAR-29-002 solicits development of research models and new approach methodologies with broad applicability across multiple NIH institutes (due September 16, 2026). PAR-28-084 seeks applications for genome editing testing centers to evaluate somatic cell editing approaches (due October 13, 2026). PAR-27-022 consolidates three shared instrumentation programs (SIG) with awards from $300,000 to $5 million (due July 1, 2028).

Objective and description

Objective

The Office of Research Infrastructure Programs (ORIP) is a program office in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) dedicated to supporting research infrastructure and related research resource programs. OR

Description

ORIP advances the NIH mission by supporting infrastructure for innovation. This support is focused on research resources, including research models for human diseases, cutting-edge scientific instrumentation, construction and modernization of research facilities, and research training opportunities for veterinary scientists.

Eligibility

Applicant eligibility

Institutions of higher education, hospitals, and other institutions and organizations, both nonprofit and for-profit, seeking to establish, continue, or enlarge programs consistent with the objectives of the program. To be eligible for instrumentation and equipment programs, applications must be Private nonprofit institutions/organizations, Public nonprofit institutions/organizations. Applicants for NRSA must be citizens of the United States or be admitted to the United States for permanent residency. Applicants must be nominated and sponsored by a public or private nonprofit institution with staff and facilities suitable for the proposed research training. Nonprofit domestic organizations may apply for the institutional NRSA. Research Career Development: Applications may be submitted on behalf of candidates by domestic, nonfederal organizations, public or private institutions of higher education.

Beneficiary eligibility

Private nonprofit institutions/organizations, Public nonprofit institutions/organizations are eligible for instrumentation and equipment programs. Biomedical investigators at any nonprofit organization or institution engaged in biomedical research.

Uses of assistance

The Division of Comparative Medicine (DCM) helps meet the needs of biomedical researchers for high-quality, disease-free animals and specialized animal research facilities as well as supports the development of the biomedical workforce, specifically scientists with a background in veterinary medicine. Additionally, DCM seeks to increase small business participation in federally supported research and development as well as the private-sector commercialization of technology developed with federal support. It does this through the federal government's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The Division of Construction and Instruments: This Division supports programs to expand the Nation's capacity for the conduct of biomedical research by offering grants for the acquisition of state-of the-art biomedical research instrumentation and integrated instrument systems, advanced biomedical laboratory equipment, and, when specially appropriated funds are available, grants for construction and modernization of biomedical and biobehavioral research facilities.

Length and time phasing of assistance

All programs: 1 to 5 years. Research Grants, Cooperative Agreements, Center Grants, and NRSA Institutional grants may be awarded for up to 5 years, generally in 12-month budget periods and may be extended through a competitive renewal. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. Shared Instrumentation Grants are awarded for 12 months. The Council of Councils may recommend funding for periods ranging from 1 to 5 years. Funding commitments are made annually. Award length may vary depending on the recommendation of the scientific review group, the national advisory council, successful annual performance, and availability of funds. A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. Method of awarding/releasing assistance: An Electronic Transfer System is used for transferring

How to apply

Preapplication coordination

Contact the headquarters, as appropriate.

Criteria for selecting proposals

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The major elements in evaluating proposals for scientific instruments include assessments of (1) the need for the instruments; (2) technical expertise in the requested technology; (3) advancements of research projects when the novel technology is available; (4) administration of the usage of the instrument and (5) institutional support for the long term maintenance and the usage of the instrument.

Award procedure

The initial review of applications from eligible investigators and institutions is reviewed by committees comprised of authorities in various fields of biomedical research and science education, as appropriate. Each application is given a peer evaluation for merit, and recommendations are forwarded to the NIH Council of Councils for final review and recommendation.

Renewals

Renewal applications are reviewed in the same manner as new applications.

Appeals

From 60 to 90 days, the institutional official (and the principal investigator) may communicate questions related to the substantive or procedural aspects of the review of their application by communicating with the NIH staff. Additional information on the appeals of initial review can be found in the NIH Guide Notices NOT-OD-11-064: Appeals of NIH Peer Review, and NOT-OD-18-197: NIH/AHRQ Application Submission/Resubmission Policy

Grant opportunities

Opportunity Status Posted Applications due
Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed) PAR-28-084 Forecasted —
Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed) PAR-29-002 Forecasted —
Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources (S15 Clinical Trial Not Allowed) PAR-28-060 Forecasted —
Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed) PAR-28-019 Forecasted —
National Biomedical Research Centers (P50 Clinical Trial Optional) PAR-28-017 Forecasted —
Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) PAR-27-029 Forecasted —
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed) PAR-27-021 Open
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) RFA-OD-27-003 Open
INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) RFA-OD-27-004 Open
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) PAR-27-022 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) PAR-27-067 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) RFA-OD-25-012 Closed
Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) RFA-OD-25-011 Open
Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) RFA-OD-25-010 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) PA-25-280 Open
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 Open
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 Open
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed) PAR-25-214 Closed
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed) PAR-25-176 Closed
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) PAR-25-165 Closed
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) PA-25-168 Open
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) PAR-25-273 Open
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) PAR-25-185 Open
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) PAR-24-326 Closed
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) PAR-24-265 Closed
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) PAR-24-264 Closed
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) PA-25-212 Closed
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01 Clinical Trial Not Allowed) PAR-25-076 Closed
Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed) PAR-24-305 Closed
Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-24-255 Closed
Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed) PAR-24-258 Closed
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed) PAR-24-259 Closed
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 Open
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 Open
PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-24-247 Closed
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-24-245 Closed
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) PA-24-176 Open
Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed) PAR-24-167 Closed
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-24-141 Closed
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) PAR-24-129 Closed
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) PAR-24-078 Closed
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) PAR-24-105 Closed
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-24-075 Closed
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
12TH aquatic models of human diseases conference R13OD042688 William Marsh Rice University $30,000
Modernizing sterilization infrastructure for reliable and economical rodent barrier operations S15OD042593 The Trustees Of Columbia University In The City Of New York $350,000
Modernization of the shielded laminar flow environment for molecular probe manufacture S15OD042592 Vanderbilt University Medical Center $210,120
Biomek I7 hybrid automated liquid handler to support biomedical research and discovery S15OD042591 Yale Univ $345,676
Transforming drug discovery research at the university of chicago via acoustic liquid handler-echo 650 S15OD042589 The University Of Chicago $350,000
Advancing and modernizing germ-free and gnotobiotic operations to facilitate microbiome-related research S15OD042583 Cornell University $349,982
Acquisition of a beckman biomek I7 automated workstation for high-throughput screening core facility S15OD042581 Regents Of The University Of Michigan $348,594
Modernizing bottle processing within the mclaughlin research institute's animal resource center (ARC) S15OD042573 The Mclaughlin Research Institute For Biomedical Sciences, Inc. $190,745
Roche discovery ultra S15OD042572 J.david Gladstone Institutes $175,000
Digitized caging system for rodent behavioral core: enhanced monitoring, efficient operations, and improved rigor and… S15OD042567 Seattle Children's Hospital $350,000

Latest 10 of 2,768 listed here. See the rest on GovTribe.

Top recipients by federal obligations

Rank Recipient Federal obligations Share
1 Oregon Health & Science University $489,948,612 9%
2 University Of Washington $481,053,120 8%
3 University Of Wisconsin System $417,729,608 7%
4 The Administrators Of Tulane Educational Fund $386,233,508 7%
5 Emory University $380,435,747 7%
6 University Of California, Davis $213,728,761 4%
7 University Of Missouri System $149,439,789 3%
8 Jackson Laboratory $141,273,219 2%
9 University Of Puerto Rico Medical Sciences Campus $120,965,786 2%
10 University Of North Carolina At Chapel Hill $95,720,460 2%

10 of 443 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $328,607,559
FY2025 $504,831,476
FY2024 $736,673,396
FY2023 $886,740,309
FY2022 $863,047,006
FY2021 $558,701,187
FY2020 $300,664,701
FY2019 $292,697,617
FY2018 $292,494,292
FY2017 $265,232,117
FY2016 $290,262,515
FY2015 $283,045,724
FY2014 $278,670,876
FY2013 $267,323,355
FY2012 $274,300,368
Show all 15

Quick answers

What is Assistance Listing 93.351?

Assistance Listing 93.351 is Research Infrastructure Programs, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Research Infrastructure Programs?

Its CFDA number is 93.351: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.351 awarded?

2,768 grant awards under 93.351 have obligated $5,728,088,538 in federal funds to 443 recipients.

Who receives the most funding from 93.351?

The recipients obligated the most under Research Infrastructure Programs are Oregon Health & Science University ($489,948,612), University Of Washington ($481,053,120) and University Of Wisconsin System ($417,729,608).

How much did 93.351 obligate in fiscal year 2025?

Grants under 93.351 obligated $504,831,476 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.351?

29 of the latest 50 opportunities under 93.351 are open or forecasted. The latest, Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed), was posted on October 13, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program